Joint associations of lung function of both general and abdominal obesity with cardiometabolic multimorbidity: a
Shuyan Wan1, Mengmeng Shi1, Yue Gao2
1Department of Health Education, Jinhua Municipal Central Hospital, Zhejiang, China.
Background:
Cardiometabolic multimorbidity (CMM) has become an escalating public health challenge amid global population aging. Although lung function has been implicated in individual cardiometabolic conditions, its role in predicting CMM, particularly in relation to obesity, remains poorly characterized. This study aimed to evaluate the associations between lung function indicators and CMM, and to explore their joint associations with general and abdominal obesity.
Methods:
This cross-sectional study included 35,414 community-dwelling adults aged ≥65 years from the Zhejiang Provincial Chronic Obstructive Lung Disease Screening in Jinhua City, China. Lung function was assessed by standardized spirometry. Participants were classified as having preserved lung function or restrictive spirometry (FEV₁/FVC ≥ 0.70 with FVC%predicted <80%). General obesity was defined as BMI ≥ 28.0 kg/m2, and abdominal obesity as waist circumference ≥90 cm (men) or ≥85 cm (women). CMM was defined as coexistence of ≥2 conditions: type 2 diabetes, coronary heart disease, or stroke. Multivariable logistic regression models examined associations of lung function and obesity with CMM, adjusting for demographic, lifestyle, and clinical factors. Joint effects and dose-response relationships were assessed.
Results:
CMM prevalence was 1.02%. In fully adjusted models, higher lung function was inversely associated with CMM. Compared to the lowest quartile, the highest quartile had significantly lower CMM odds for FVC%predicted (OR = 0.60, 95%CI: 0.44, 0.81), FEV₁%predicted (OR = 0.71, 95%CI: 0.53, 0.95), and PEF%predicted (OR = 0.64, 95%CI: 0.47, 0.86). Restrictive spirometry was associated with 56% higher CMM odds versus preserved lung function. Both general obesity (OR = 1.30 per SD, 95%CI: 1.18, 1.43) and abdominal obesity (OR = 1.33 per SD, 95%CI: 1.21, 1.45) significantly increased CMM odds. Joint analysis showed participants with restrictive spirometry and abdominal obesity had the highest CMM, while those with preserved lung function and normal abdominal circumference had 65% lower odds (OR = 0.35, 95%CI: 0.25, 0.49).
Conclusion:
These findings suggest that reduced lung function in combination with obesity represents a high-risk phenotype that is more strongly associated with CMM. Simultaneous screening of lung function and obesity status may help identify older adults at greatest risk for CMM. However, longitudinal studies are warranted to confirm the temporality of these associations.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma